{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:23:40Z","timestamp":1785551020707,"version":"3.56.0"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2012,10,9]],"date-time":"2012-10-09T00:00:00Z","timestamp":1349740800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1038\/nrurol.2012.178","type":"journal-article","created":{"date-parts":[[2012,10,9]],"date-time":"2012-10-09T09:19:56Z","timestamp":1349774396000},"page":"628-637","source":"Crossref","is-referenced-by-count":96,"title":["Neurotrophins as regulators of urinary bladder function"],"prefix":"10.1038","volume":"9","author":[{"given":"Peter","family":"Ochodnicky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9lia D.","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,9]]},"reference":[{"key":"BFnrurol2012178_CR1","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrn2401","volume":"9","author":"CJ Fowler","year":"2008","unstructured":"Fowler, C. J., Griffiths, D. & de Groat, W. C. The neural control of micturition. Nat. Rev. Neurosci. 9, 453\u2013466 (2008).","journal-title":"Nat. Rev. Neurosci."},{"key":"BFnrurol2012178_CR2","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/MOU.0b013e32819ed7f9","volume":"17","author":"H Hashim","year":"2007","unstructured":"Hashim, H. & Abrams, P. Overactive bladder: an update. Curr. Opin. Urol. 17, 231\u2013236 (2007).","journal-title":"Curr. Opin. Urol."},{"key":"BFnrurol2012178_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0090-4295(02)02243-4","volume":"61","author":"P Abrams","year":"2003","unstructured":"Abrams, P. et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 61, 37\u201349 (2003).","journal-title":"Urology"},{"key":"BFnrurol2012178_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/978-3-540-79090-7_4","volume":"194","author":"WC de Groat","year":"2009","unstructured":"de Groat, W. C. & Yoshimura, N. Afferent nerve regulation of bladder function in health and disease. Handb. Exp. Pharmacol. 194, 91\u2013138 (2009).","journal-title":"Handb. Exp. Pharmacol."},{"key":"BFnrurol2012178_CR5","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.juro.2009.12.060","volume":"183","author":"A Kanai","year":"2010","unstructured":"Kanai, A. & Andersson, K. E. Bladder afferent signaling: recent findings. J. Urol. 183, 1288\u20131295 (2010).","journal-title":"J. Urol."},{"key":"BFnrurol2012178_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.eururo.2008.03.086","volume":"54","author":"M Fall","year":"2008","unstructured":"Fall, M., Oberpenning, F. & Peeker, R. Treatment of bladder pain syndrome\/interstitial cystitis can we make evidence-based decisions? Eur. Urol. 54, 65\u201375 (2008).","journal-title":"Eur. Urol."},{"key":"BFnrurol2012178_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/nau.20847","volume":"29","author":"P Hanno","year":"2010","unstructured":"Hanno, P. et al. Bladder Pain Syndrome Committee of the International Consultation on Incontinence. Neurourol. Urodyn. 29, 191\u2013198 (2010).","journal-title":"Neurourol. Urodyn."},{"key":"BFnrurol2012178_CR8","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1016\/S0022-5347(05)64291-7","volume":"168","author":"OJ Wiseman","year":"2002","unstructured":"Wiseman, O. J. et al. The ultrastructure of bladder lamina propria nerves in healthy subjects and patients with detrusor hyperreflexia. J. Urol. 168, 2040\u20132045 (2002).","journal-title":"J. Urol."},{"key":"BFnrurol2012178_CR9","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/sj.ki.5002439","volume":"72","author":"G Apodaca","year":"2007","unstructured":"Apodaca, G., Balestreire, E. & Birder, L. A. The uroepithelial-associated sensory web. Kidney Int. 72, 1057\u20131064 (2007).","journal-title":"Kidney Int."},{"key":"BFnrurol2012178_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/ncpuro0672","volume":"4","author":"LA Birder","year":"2007","unstructured":"Birder, L. A. & de Groat, W. C. Mechanisms of disease: involvement of the urothelium in bladder dysfunction. Nat. Clin. Pract. Urol. 4, 46\u201354 (2007).","journal-title":"Nat. Clin. Pract. Urol."},{"key":"BFnrurol2012178_CR11","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1146\/annurev.neuro.29.051605.112929","volume":"29","author":"S Pezet","year":"2006","unstructured":"Pezet, S. & McMahon, S. B. Neurotrophins: mediators and modulators of pain. Ann. Rev. Neurosci. 29, 507\u2013538 (2006).","journal-title":"Ann. Rev. Neurosci."},{"key":"BFnrurol2012178_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/nau.20784","volume":"29","author":"KE Andersson","year":"2010","unstructured":"Andersson, K. E. Detrusor myocyte activity and afferent signaling. Neurourol. Urodyn. 29, 97\u2013106 (2010).","journal-title":"Neurourol. Urodyn."},{"key":"BFnrurol2012178_CR13","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1111\/j.1464-410X.2009.08377.x","volume":"103","author":"JI Gillespie","year":"2009","unstructured":"Gillespie, J. I., van Koeveringe, G. A., de Wachter, S. G. & de Vente, J. On the origins of the sensory output from the bladder: the concept of afferent noise. BJU Int. 103, 1324\u20131333 (2009).","journal-title":"BJU Int."},{"key":"BFnrurol2012178_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0304-3940(02)00598-0","volume":"329","author":"T Kawakami","year":"2002","unstructured":"Kawakami, T., Wakabayashi, Y., Isono, T., Aimi, Y. & Okada, Y. Expression of neurotrophin messenger RNAs during rat urinary bladder development. Neurosci. Lett. 329, 77\u201380 (2002).","journal-title":"Neurosci. Lett."},{"key":"BFnrurol2012178_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0165-3806(99)00174-1","volume":"119","author":"MA Vizzard","year":"2000","unstructured":"Vizzard, M. A., Wu, K. H. & Jewett, I. T. Developmental expression of urinary bladder neurotrophic factor mRNA and protein in the neonatal rat. Brain Res. Dev. Brain Res. 119, 217\u2013224 (2000).","journal-title":"Brain Res. Dev. Brain Res."},{"key":"BFnrurol2012178_CR16","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/jez.1401160206","volume":"116","author":"R Levi-Montalcini","year":"1951","unstructured":"Levi-Montalcini, R. & Hamburger, V. Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo. J. Exp. Zool. 116, 321\u2013361 (1951).","journal-title":"J. Exp. Zool."},{"key":"BFnrurol2012178_CR17","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1126\/science.3306916","volume":"237","author":"R Levi-Montalcini","year":"1987","unstructured":"Levi-Montalcini, R. The nerve growth factor 35 years later. Science 237, 1154\u20131162 (1987).","journal-title":"Science"},{"key":"BFnrurol2012178_CR18","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00441-009-0784-z","volume":"336","author":"U Ernsberger","year":"2009","unstructured":"Ernsberger, U. Role of neurotrophin signalling in the differentiation of neurons from dorsal root ganglia and sympathetic ganglia. Cell Tissue Res. 336, 349\u2013384 (2009).","journal-title":"Cell Tissue Res."},{"key":"BFnrurol2012178_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0006-8993(92)91341-B","volume":"588","author":"JB Tuttle","year":"1992","unstructured":"Tuttle, J. B. & Steers, W. D. Nerve growth factor responsiveness of cultured major pelvic ganglion neurons from the adult rat. Brain Res. 588, 29\u201340 (1992).","journal-title":"Brain Res."},{"key":"BFnrurol2012178_CR20","doi-asserted-by":"publisher","first-page":"R534","DOI":"10.1152\/ajpregu.00367.2009","volume":"298","author":"B Schnegelsberg","year":"2010","unstructured":"Schnegelsberg, B. et al. Overexpression of NGF in mouse urothelium leads to neuronal hyperinnervation, pelvic sensitivity, and changes in urinary bladder function. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298, R534\u2013R547 (2010).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"BFnrurol2012178_CR21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0169-328X(01)00314-X","volume":"97","author":"SD Skaper","year":"2001","unstructured":"Skaper, S. D., Pollock, M. & Facci, L. Mast cells differentially express and release active high molecular weight neurotrophins. Brain Res. Mol. Brain Res. 97, 177\u2013185 (2001).","journal-title":"Brain Res. Mol. Brain Res."},{"key":"BFnrurol2012178_CR22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1385\/MN:24:1-3:183","volume":"24","author":"SD Skaper","year":"2001","unstructured":"Skaper, S. D. Nerve growth factor: a neurokine orchestrating neuroimmune-endocrine functions. Mol. Neurobiol. 24, 183\u2013199 (2001).","journal-title":"Mol. Neurobiol."},{"key":"BFnrurol2012178_CR23","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1464-410X.2006.06207.x","volume":"98","author":"J Jang","year":"2006","unstructured":"Jang, J., Park, E. Y., Seo, S. I., Hwang, T. K. & Kim, J. C. Effects of intravesical instillation of cyclooxygenase-2 inhibitor on the expression of inducible nitric oxide synthase and nerve growth factor in cyclophosphamide-induced overactive bladder. BJU Int. 98, 435\u2013439 (2006).","journal-title":"BJU Int."},{"key":"BFnrurol2012178_CR24","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1097\/01.ju.0000143192.68223.f7","volume":"173","author":"RR Gonzalez","year":"2005","unstructured":"Gonzalez, R. R. et al. Modulating bladder neuro-inflammation: RDP58, a novel anti-inflammatory peptide, decreases inflammation and nerve growth factor production in experimental cystitis. J. Urol. 173, 630\u2013634 (2005).","journal-title":"J. Urol."},{"key":"BFnrurol2012178_CR25","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1097\/01.ju.0000115883.49365.1a","volume":"171","author":"KL Meyer-Siegler","year":"2004","unstructured":"Meyer-Siegler, K. L. & Vera, P. L. Substance P induced release of macrophage migration inhibitory factor from rat bladder epithelium. J. Urol. 171, 1698\u20131703 (2004).","journal-title":"J. Urol."},{"key":"BFnrurol2012178_CR26","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/S0022-5347(05)65931-9","volume":"166","author":"MC Dupont","year":"2001","unstructured":"Dupont, M. C., Spitsbergen, J. M., Kim, K. B., Tuttle, J. B. & Steers, W. D. Histological and neurotrophic changes triggered by varying models of bladder inflammation. J. Urol. 166, 1111\u20131118 (2001).","journal-title":"J. Urol."},{"key":"BFnrurol2012178_CR27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/ALN.0b013e31821b1ac5","volume":"115","author":"PW Mantyh","year":"2011","unstructured":"Mantyh, P. W., Koltzenburg, M., Mendell, L. M., Tive, L. & Shelton, D. L. Antagonism of nerve growth factor-TrkA signaling and the relief of pain. Anesthesiology 115, 189\u2013204 (2011).","journal-title":"Anesthesiology"},{"key":"BFnrurol2012178_CR28","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1001\/jama.284.17.2215","volume":"284","author":"SC Apfel","year":"2000","unstructured":"Apfel, S. C. et al. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: a randomized controlled trial. rhNGF Clinical Investigator Group. JAMA 284, 2215\u20132221 (2000).","journal-title":"JAMA"},{"key":"BFnrurol2012178_CR29","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/nn938","volume":"5","author":"H Thoenen","year":"2002","unstructured":"Thoenen, H. & Sendtner, M. Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches. Nat. Neurosci. 5, 1046\u20131050 (2002).","journal-title":"Nat. Neurosci."},{"key":"BFnrurol2012178_CR30","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/ncpuro0408","volume":"3","author":"WD Steers","year":"2006","unstructured":"Steers, W. D. & Tuttle, J. B. Mechanisms of Disease: the role of nerve growth factor in the pathophysiology of bladder disorders. Nat. Clin. Pract. Urol. 3, 101\u2013110 (2006).","journal-title":"Nat. Clin. Pract. Urol."},{"key":"BFnrurol2012178_CR31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0304-3959(96)02993-4","volume":"66","author":"N Dmitrieva","year":"1996","unstructured":"Dmitrieva, N. & McMahon, S. B. Sensitisation of visceral afferents by nerve growth factor in the adult rat. Pain 66, 87\u201397 (1996).","journal-title":"Pain"},{"key":"BFnrurol2012178_CR32","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S0306-4522(96)00575-1","volume":"78","author":"N Dmitrieva","year":"1997","unstructured":"Dmitrieva, N., Shelton, D., Rice, A. S. & McMahon, S. B. The role of nerve growth factor in a model of visceral inflammation. Neuroscience 78, 449\u2013459 (1997).","journal-title":"Neuroscience"},{"key":"BFnrurol2012178_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1472-6793-7-9","volume":"7","author":"P Zvara","year":"2007","unstructured":"Zvara, P. & Vizzard, M. A. Exogenous overexpression of nerve growth factor in the urinary bladder produces bladder overactivity and altered micturition circuitry in the lumbosacral spinal cord. BMC Physiol. 7, 9 (2007).","journal-title":"BMC Physiol."},{"key":"BFnrurol2012178_CR34","doi-asserted-by":"publisher","first-page":"10847","DOI":"10.1523\/JNEUROSCI.3023-06.2006","volume":"26","author":"N Yoshimura","year":"2006","unstructured":"Yoshimura, N. et al. Bladder overactivity and hyperexcitability of bladder afferent neurons after intrathecal delivery of nerve growth factor in rats. J. Neurosci. 26, 10847\u201310855 (2006).","journal-title":"J. Neurosci."},{"key":"BFnrurol2012178_CR35","doi-asserted-by":"publisher","unstructured":"Frias, B. et al. TRPV1 mediates NGF-induced bladder overactivity and noxious input. BJU Int. http:\/\/dx.doi.org\/10.1111\/j.1464-410X.2012.11187.x","DOI":"10.1111\/j.1464-410X.2012.11187.x"},{"key":"BFnrurol2012178_CR36","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0304-3959(00)00370-5","volume":"89","author":"J Winston","year":"2001","unstructured":"Winston, J., Toma, H., Shenoy, M. & Pasricha, P. J. Nerve growth factor regulates VR-1 mRNA levels in cultures of adult dorsal root ganglion neurons. Pain 89, 181\u2013186 (2001).","journal-title":"Pain"},{"key":"BFnrurol2012178_CR37","doi-asserted-by":"publisher","first-page":"8300","DOI":"10.1523\/JNEUROSCI.2893-04.2004","volume":"24","author":"ZY Zhuang","year":"2004","unstructured":"Zhuang, Z. Y., Xu, H., Clapham, D. E. & Ji, R. R. Phosphatidylinositol 3-kinase activates ERK in primary sensory neurons and mediates inflammatory heat hyperalgesia through TRPV1 sensitization. J. Neurosci. 24, 8300\u20138309 (2004).","journal-title":"J. Neurosci."},{"key":"BFnrurol2012178_CR38","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1016\/j.juro.2009.08.022","volume":"182","author":"A Charrua","year":"2009","unstructured":"Charrua, A. et al. Functional transient receptor potential vanilloid 1 is expressed in human urothelial cells. J. Urol. 182, 2944\u20132950 (2009).","journal-title":"J. Urol."},{"key":"BFnrurol2012178_CR39","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/0092-8674(94)90048-5","volume":"77","author":"WD Snider","year":"1994","unstructured":"Snider, W. D. Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. Cell 77, 627\u2013638 (1994).","journal-title":"Cell"},{"key":"BFnrurol2012178_CR40","doi-asserted-by":"publisher","first-page":"e1707","DOI":"10.1371\/journal.pone.0001707","volume":"3","author":"XY Song","year":"2008","unstructured":"Song, X. Y., Li, F., Zhang, F. H., Zhong, J. H. & Zhou, X. F. Peripherally-derived BDNF promotes regeneration of ascending sensory neurons after spinal cord injury. PLoS ONE 3, e1707 (2008).","journal-title":"PLoS ONE"},{"key":"BFnrurol2012178_CR41","doi-asserted-by":"publisher","first-page":"F345","DOI":"10.1152\/ajprenal.00515.2010","volume":"300","author":"BM Girard","year":"2011","unstructured":"Girard, B. M., Malley, S. E. & Vizzard, M. A. Neurotrophin\/receptor expression in urinary bladder of mice with overexpression of NGF in urothelium. Am. J. Physiol. Renal Physiol. 300, F345\u2013F355 (2011).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrurol2012178_CR42","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.neuroscience.2010.01.015","volume":"166","author":"R Pinto","year":"2010","unstructured":"Pinto, R. et al. Sequestration of brain derived nerve factor by intravenous delivery of TrkB-Ig2 reduces bladder overactivity and noxious input in animals with chronic cystitis. Neuroscience 166, 907\u2013916 (2010).","journal-title":"Neuroscience"},{"key":"BFnrurol2012178_CR43","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1006\/exnr.1999.7254","volume":"161","author":"MA Vizzard","year":"2000","unstructured":"Vizzard, M. A. Changes in urinary bladder neurotrophic factor mRNA and NGF protein following urinary bladder dysfunction. Exp. Neurol. 161, 273\u2013284 (2000).","journal-title":"Exp. Neurol."},{"key":"BFnrurol2012178_CR44","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0165-0173(02)00206-0","volume":"40","author":"S Pezet","year":"2002","unstructured":"Pezet, S., Malcangio, M. & McMahon, S. B. BDNF: a neuromodulator in nociceptive pathways? Brain Res. Rev. 40, 240\u2013249 (2002).","journal-title":"Brain Res. Rev."},{"key":"BFnrurol2012178_CR45","doi-asserted-by":"publisher","first-page":"8476","DOI":"10.1523\/JNEUROSCI.17-21-08476.1997","volume":"17","author":"GJ Michael","year":"1997","unstructured":"Michael, G. J. et al. Nerve growth factor treatment increases brain-derived neurotrophic factor selectively in TrkA-expressing dorsal root ganglion cells and in their central terminations within the spinal cord. J. Neurosci. 17, 8476\u20138490 (1997).","journal-title":"J. Neurosci."},{"key":"BFnrurol2012178_CR46","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.2215\/CJN.02000309","volume":"4","author":"DA Moutzouris","year":"2009","unstructured":"Moutzouris, D. A. & Falagas, M. E. Interstitial cystitis: an unsolved enigma. Clin. J. Am. Soc. Nephrol. 4, 1844\u20131857 (2009).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrurol2012178_CR47","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/j.juro.2011.03.064","volume":"185","author":"PM Hanno","year":"2011","unstructured":"Hanno, P. M. et al. AUA guideline for the diagnosis and treatment of interstitial cystitis\/bladder pain syndrome. J. Urol. 185, 2162\u20132170 (2011).","journal-title":"J. Urol."},{"key":"BFnrurol2012178_CR48","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.juro.2011.03.132","volume":"186","author":"SH Berry","year":"2011","unstructured":"Berry, S. H. et al. Prevalence of symptoms of bladder pain syndrome\/interstitial cystitis among adult females in the United States. J. Urol. 186, 540\u2013544 (2011).","journal-title":"J. Urol."},{"key":"BFnrurol2012178_CR49","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.urology.2007.04.038","volume":"70","author":"HT Liu","year":"2007","unstructured":"Liu, H. T. & Kuo, H. C. Intravesical botulinum toxin A injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis. Urology 70, 463\u2013468 (2007).","journal-title":"Urology"},{"key":"BFnrurol2012178_CR50","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.eururo.2010.02.031","volume":"58","author":"R Pinto","year":"2010","unstructured":"Pinto, R. et al. Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome\/interstitial cystitis. Eur. Urol. 58, 360\u2013365 (2010).","journal-title":"Eur. Urol."},{"key":"BFnrurol2012178_CR51","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/BF01605152","volume":"416","author":"TJ Christmas","year":"1990","unstructured":"Christmas, T. J., Rode, J., Chapple, C. R., Milroy, E. J. & Turner-Warwick, R. T. Nerve fibre proliferation in interstitial cystitis. Virchows Arch. A Pathol. Anat. Histopathol. 416, 447\u2013451 (1990).","journal-title":"Virchows Arch. A Pathol. Anat. Histopathol."},{"key":"BFnrurol2012178_CR52","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1464-410X.1991.tb15388.x","volume":"68","author":"TJ Christmas","year":"1991","unstructured":"Christmas, T. J. & Rode, J. Characteristics of mast cells in normal bladder, bacterial cystitis and interstitial cystitis. Br. J. Urol. 68, 473\u2013478 (1991).","journal-title":"Br. J. Urol."},{"key":"BFnrurol2012178_CR53","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/nau.21109","volume":"30","author":"LA Birder","year":"2011","unstructured":"Birder, L. A., Hanna-Mitchell, A. T., Mayer, E. & Buffington, C. A. Cystitis, co-morbid disorders and associated epithelial dysfunction. Neurourol. Urodyn. 30, 668\u2013672 (2011).","journal-title":"Neurourol. Urodyn."},{"key":"BFnrurol2012178_CR54","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/ncpuro0057","volume":"1","author":"TC Chai","year":"2004","unstructured":"Chai, T. C. & Keay, S. New theories in interstitial cystitis. Nat. Clin. Pract. Urol. 1, 85\u201389 (2004).","journal-title":"Nat. Clin. Pract. Urol."},{"key":"BFnrurol2012178_CR55","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1046\/j.1464-410X.1997.00097.x","volume":"79","author":"EM Lowe","year":"1997","unstructured":"Lowe, E. M. et al. Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis. Br. J. Urol. 79, 572\u2013577 (1997).","journal-title":"Br. J. Urol."},{"key":"BFnrurol2012178_CR56","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/ncpuro1124","volume":"5","author":"MB Chancellor","year":"2008","unstructured":"Chancellor, M. B. et al. Drug Insight: biological effects of botulinum toxin A in the lower urinary tract. Nat. Clin. Pract. Urol. 5, 319\u2013328 (2008).","journal-title":"Nat. Clin. Pract. Urol."},{"key":"BFnrurol2012178_CR57","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1111\/j.1464-410X.2009.08675.x","volume":"104","author":"HT Liu","year":"2009","unstructured":"Liu, H. T., Tyagi, P., Chancellor, M. B. & Kuo, H. C. Urinary nerve growth factor level is increased in patients with interstitial cystitis\/bladder pain syndrome and decreased in responders to treatment. BJU Int. 104, 1476\u20131481 (2009).","journal-title":"BJU Int."},{"key":"BFnrurol2012178_CR58","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.eururo.2010.02.031","volume":"58","author":"R Pinto","year":"2010","unstructured":"Pinto, R. et al. Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome\/interstitial cystitis. Eur. Urol. 58, 360\u2013365 (2010).","journal-title":"Eur. Urol."},{"key":"BFnrurol2012178_CR59","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1021\/mp050093x","volume":"3","author":"P Tyagi","year":"2006","unstructured":"Tyagi, P. et al. Intravesical antisense therapy for cystitis using TAT-peptide nucleic acid conjugates. Mol. Pharm. 3, 398\u2013406 (2006).","journal-title":"Mol. Pharm."},{"key":"BFnrurol2012178_CR60","first-page":"708","volume":"28","author":"B Frias","year":"2009","unstructured":"Frias, B. et al. Intrathecal blockade of Trk receptor and neurotrophins sequestration reduces pain and urinary frequency in an animal model of chronic bladder inflammation. Neurourol. Urodyn. 28, 708 (2009).","journal-title":"Neurourol. Urodyn."},{"key":"BFnrurol2012178_CR61","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1097\/01.ju.0000155170.15023.e5","volume":"173","author":"VY Hu","year":"2005","unstructured":"Hu, V. Y. et al. Decrease in bladder overactivity with REN1820 in rats with cyclophosphamide induced cystitis. J. Urol. 173, 1016\u20131021 (2005).","journal-title":"J. Urol."},{"key":"BFnrurol2012178_CR62","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1016\/j.juro.2010.12.088","volume":"185","author":"RJ Evans","year":"2011","unstructured":"Evans, R. J. et al. Proof of concept trial of tanezumab for the treatment of symptoms associated with interstitial cystitis. J. Urol. 185, 1716\u20131721 (2011).","journal-title":"J. Urol."},{"key":"BFnrurol2012178_CR63","unstructured":"US National Library of Medicine. ClinicalTrials.gov [online] , (2011)."},{"key":"BFnrurol2012178_CR64","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1056\/NEJMe1004416","volume":"363","author":"JN Wood","year":"2010","unstructured":"Wood, J. N. Nerve growth factor and pain. N. Engl. J. Med. 363, 1572\u20131573 (2010).","journal-title":"N. Engl. J. Med."},{"key":"BFnrurol2012178_CR65","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.expneurol.2011.05.003","volume":"235","author":"WC de Groat","year":"2012","unstructured":"de Groat, W. C. & Yoshimura, N. Plasticity in reflex pathways to the lower urinary tract following spinal cord injury. Exp. Neurol. 235, 123\u2013132 (2012).","journal-title":"Exp. Neurol."},{"key":"BFnrurol2012178_CR66","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ncpuro0323","volume":"2","author":"V Kalsi","year":"2005","unstructured":"Kalsi, V. & Fowler, C. J. Therapy Insight: bladder dysfunction associated with multiple sclerosis. Nat. Clin. Pract. Urol. 2, 492\u2013501 (2005).","journal-title":"Nat. Clin. Pract. Urol."},{"key":"BFnrurol2012178_CR67","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1097\/01.ju.0000169481.42259.54","volume":"174","author":"A Apostolidis","year":"2005","unstructured":"Apostolidis, A. et al. Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. J. Urol. 174, 977\u2013982 (2005).","journal-title":"J. Urol."},{"key":"BFnrurol2012178_CR68","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.eururo.2008.04.037","volume":"56","author":"HT Liu","year":"2009","unstructured":"Liu, H. T., Chancellor, M. B. & Kuo, H. C. Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection. Eur. Urol. 56, 700\u2013706 (2009).","journal-title":"Eur. Urol."},{"key":"BFnrurol2012178_CR69","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1016\/S0022-5347(06)00258-8","volume":"175","author":"A Giannantoni","year":"2006","unstructured":"Giannantoni, A. et al. Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity. J. Urol. 175, 2341\u20132344 (2006).","journal-title":"J. Urol."},{"key":"BFnrurol2012178_CR70","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1002\/cne.20195","volume":"475","author":"K Zvarova","year":"2004","unstructured":"Zvarova, K., Murray, E. & Vizzard, M. A. Changes in galanin immunoreactivity in rat lumbosacral spinal cord and dorsal root ganglia after spinal cord injury. J. Comp. Neurol. 475, 590\u2013603 (2004).","journal-title":"J. Comp. Neurol."},{"key":"BFnrurol2012178_CR71","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1016\/S0022-5347(01)64918-8","volume":"157","author":"K Persson","year":"1997","unstructured":"Persson, K., Steers, W. D. & Tuttle, J. B. Regulation of nerve growth factor secretion in smooth muscle cells cultured from rat bladder body, base and urethra. J. Urol. 157, 2000\u20132006 (1997).","journal-title":"J. Urol."},{"key":"BFnrurol2012178_CR72","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1046\/j.1464-410x.2000.00562.x","volume":"85","author":"R Tanner","year":"2000","unstructured":"Tanner, R., Chambers, P., Khadra, M. H. & Gillespie, J. I. The production of nerve growth factor by human bladder smooth muscle cells in vivo and in vitro. BJU Int. 85, 1115\u20131119 (2000).","journal-title":"BJU Int."},{"key":"BFnrurol2012178_CR73","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1046\/j.1471-4159.2001.00288.x","volume":"77","author":"MS Ramer","year":"2001","unstructured":"Ramer, M. S., Bradbury, E. J. & McMahon, S. B. Nerve growth factor induces P2X(3) expression in sensory neurons. J. Neurochem. 77, 864\u2013875 (2001).","journal-title":"J. Neurochem."},{"key":"BFnrurol2012178_CR74","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1016\/S0022-5347(05)64369-8","volume":"168","author":"S Seki","year":"2002","unstructured":"Seki, S. et al. Immunoneutralization of nerve growth factor in lumbosacral spinal cord reduces bladder hyperreflexia in spinal cord injured rats. J. Urol. 168, 2269\u20132274 (2002).","journal-title":"J. Urol."},{"key":"BFnrurol2012178_CR75","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1097\/01.ju.0000088340.26588.74","volume":"171","author":"S Seki","year":"2004","unstructured":"Seki, S. et al. Suppression of detrusor-sphincter dyssynergia by immunoneutralization of nerve growth factor in lumbosacral spinal cord in spinal cord injured rats. J. Urol. 171, 478\u2013482 (2004).","journal-title":"J. Urol."},{"key":"BFnrurol2012178_CR76","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.eururo.2006.07.050","volume":"51","author":"V Mirone","year":"2007","unstructured":"Mirone, V., Imbimbo, C., Longo, N. & Fusco, F. The detrusor muscle: an innocent victim of bladder outlet obstruction. Eur. Urol. 51, 57\u201366 (2007).","journal-title":"Eur. Urol."},{"key":"BFnrurol2012178_CR77","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1172\/JCI115488","volume":"88","author":"WD Steers","year":"1991","unstructured":"Steers, W. D., Kolbeck, S., Creedon, D. & Tuttle, J. B. Nerve growth factor in the urinary bladder of the adult regulates neuronal form and function. J. Clin. Invest. 88, 1709\u20131715 (1991).","journal-title":"J. Clin. Invest."},{"key":"BFnrurol2012178_CR78","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S0022-5347(01)66664-3","volume":"155","author":"WD Steers","year":"1996","unstructured":"Steers, W. D., Creedon, D. J. & Tuttle, J. B. Immunity to nerve growth factor prevents afferent plasticity following urinary bladder hypertrophy. J. Urol. 155, 379\u2013385 (1996).","journal-title":"J. Urol."},{"key":"BFnrurol2012178_CR79","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.urology.2008.01.069","volume":"72","author":"HT Liu","year":"2008","unstructured":"Liu, H. T. & Kuo, H. C. Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment. Urology 72, 104\u2013108 (2008).","journal-title":"Urology"},{"key":"BFnrurol2012178_CR80","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/j.1442-2042.2005.01140.x","volume":"12","author":"JC Kim","year":"2005","unstructured":"Kim, J. C. et al. Changes of urinary nerve growth factor and prostaglandins in male patients with overactive bladder symptom. Int. J. Urol. 12, 875\u2013880 (2005).","journal-title":"Int. J. Urol."},{"key":"BFnrurol2012178_CR81","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/nau.20519","volume":"27","author":"T Yokoyama","year":"2008","unstructured":"Yokoyama, T., Kumon, H. & Nagai, A. Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder. Neurourol. Urodyn. 27, 417\u2013420 (2008).","journal-title":"Neurourol. Urodyn."},{"key":"BFnrurol2012178_CR82","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1111\/j.1464-4096.2003.05059.x","volume":"94","author":"JC Kim","year":"2004","unstructured":"Kim, J. C., Kim, D. B., Seo, S. I., Park, Y. H. & Hwang, T. K. Nerve growth factor and vanilloid receptor expression, and detrusor instability, after relieving bladder outlet obstruction in rats. BJU Int. 94, 915\u2013918 (2004).","journal-title":"BJU Int."},{"key":"BFnrurol2012178_CR83","doi-asserted-by":"publisher","first-page":"C1018","DOI":"10.1152\/ajpcell.1995.269.4.C1018","volume":"269","author":"K Persson","year":"1995","unstructured":"Persson, K., Sando, J. J., Tuttle, J. B. & Steers, W. D. Protein kinase C in cyclic stretch-induced nerve growth factor production by urinary tract smooth muscle cells. Am. J. Physiol. 269, C1018\u2013C1024 (1995).","journal-title":"Am. J. Physiol."},{"key":"BFnrurol2012178_CR84","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.urology.2004.06.064","volume":"64","author":"I Araki","year":"2004","unstructured":"Araki, I. et al. Overexpression of epithelial sodium channels in epithelium of human urinary bladder with outlet obstruction. Urology 64, 1255\u20131260 (2004).","journal-title":"Urology"},{"key":"BFnrurol2012178_CR85","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/S0022-5347(05)00992-4","volume":"175","author":"JC Kim","year":"2006","unstructured":"Kim, J. C., Park, E. Y., Seo, S. I., Park, Y. H. & Hwang, T. K. Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder. J. Urol. 175, 1773\u20131776 (2006).","journal-title":"J. Urol."},{"key":"BFnrurol2012178_CR86","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/nau.20599","volume":"28","author":"HT Liu","year":"2009","unstructured":"Liu, H. T. & Kuo, H. C. Urinary nerve growth factor levels are elevated in patients with overactive bladder and do not significantly increase with bladder distention. Neurourol. Urodyn. 28, 78\u201381 (2009).","journal-title":"Neurourol. Urodyn."},{"key":"BFnrurol2012178_CR87","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1016\/j.juro.2008.01.146","volume":"179","author":"HT Liu","year":"2008","unstructured":"Liu, H. T. & Kuo, H. C. Urinary nerve growth factor level could be a potential biomarker for diagnosis of overactive bladder. J. Urol. 179, 2270\u20132274 (2008).","journal-title":"J. Urol."},{"key":"BFnrurol2012178_CR88","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/nau.20372","volume":"26","author":"LA Birder","year":"2007","unstructured":"Birder, L. A., Wolf-Johnston, A., Griffiths, D. & Resnick, N. M. Role of urothelial nerve growth factor in human bladder function. Neurourol. Urodyn. 26, 405\u2013409 (2007).","journal-title":"Neurourol. Urodyn."},{"key":"BFnrurol2012178_CR89","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1002\/nau.21118","volume":"30","author":"HT Liu","year":"2011","unstructured":"Liu, H. T., Lin, H. & Kuo, H. C. Increased serum nerve growth factor levels in patients with overactive bladder syndrome refractory to antimuscarinic therapy. Neurourol. Urodyn. 30, 1525\u20131529 (2011).","journal-title":"Neurourol. Urodyn."},{"key":"BFnrurol2012178_CR90","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1111\/j.1464-410X.2009.08380.x","volume":"103","author":"HT Liu","year":"2009","unstructured":"Liu, H. T., Chancellor, M. B. & Kuo, H. C. Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder. BJU Int. 103, 1668\u20131672 (2009).","journal-title":"BJU Int."},{"key":"BFnrurol2012178_CR91","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/nau.20741","volume":"29","author":"HC Kuo","year":"2010","unstructured":"Kuo, H. C., Liu, H. T. & Chancellor, M. B. Urinary nerve growth factor is a better biomarker than detrusor wall thickness for the assessment of overactive bladder with incontinence. Neurourol. Urodyn. 29, 482\u2013487 (2010).","journal-title":"Neurourol. Urodyn."},{"key":"BFnrurol2012178_CR92","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/nau.20422","volume":"26","author":"N Kebapci","year":"2007","unstructured":"Kebapci, N., Yenilmez, A., Efe, B., Entok, E. & Demirustu, C. Bladder dysfunction in type 2 diabetic patients. Neurourol. Urodyn. 26, 814\u2013819 (2007).","journal-title":"Neurourol. Urodyn."},{"key":"BFnrurol2012178_CR93","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.juro.2008.09.021","volume":"181","author":"WC Lee","year":"2009","unstructured":"Lee, W. C., Wu, H. P., Tai, T. Y., Yu, H. J. & Chiang, P. H. Investigation of urodynamic characteristics and bladder sensory function in the early stages of diabetic bladder dysfunction in women with type 2 diabetes. J. Urol. 181, 198\u2013203 (2009).","journal-title":"J. Urol."},{"key":"BFnrurol2012178_CR94","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/j.juro.2009.04.052","volume":"182","author":"F Daneshgari","year":"2009","unstructured":"Daneshgari, F., Liu, G., Birder, L., Hanna-Mitchell, A. T. & Chacko, S. Diabetic bladder dysfunction: current translational knowledge. J. Urol. 182, S18\u2013S26 (2009).","journal-title":"J. Urol."},{"key":"BFnrurol2012178_CR95","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0006-8993(97)01287-0","volume":"782","author":"BC Steinbacher Jr","year":"1998","unstructured":"Steinbacher, B. C. Jr & Nadelhaft, I. Increased levels of nerve growth factor in the urinary bladder and hypertrophy of dorsal root ganglion neurons in the diabetic rat. Brain Res. 782, 255\u2013260 (1998).","journal-title":"Brain Res."},{"key":"BFnrurol2012178_CR96","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/S0022-5347(05)64636-8","volume":"168","author":"K Sasaki","year":"2002","unstructured":"Sasaki, K. et al. Diabetic cystopathy correlates with a long-term decrease in nerve growth factor levels in the bladder and lumbosacral dorsal root ganglia. J. Urol. 168, 1259\u20131264 (2002).","journal-title":"J. Urol."},{"key":"BFnrurol2012178_CR97","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.2337\/diab.46.2.S43","volume":"46","author":"DR Tomlinson","year":"1997","unstructured":"Tomlinson, D. R., Fernyhough, P. & Diemel, L. T. Role of neurotrophins in diabetic neuropathy and treatment with nerve growth factors. Diabetes 46, S43\u2013S49 (1997).","journal-title":"Diabetes"},{"key":"BFnrurol2012178_CR98","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nm0696-703","volume":"2","author":"P Anand","year":"1996","unstructured":"Anand, P. et al. The role of endogenous nerve growth factor in human diabetic neuropathy. Nat. Med. 2, 703\u2013707 (1996).","journal-title":"Nat. Med."},{"key":"BFnrurol2012178_CR99","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.2337\/diabetes.53.10.2723","volume":"53","author":"K Sasaki","year":"2004","unstructured":"Sasaki, K. et al. Gene therapy using replication-defective herpes simplex virus vectors expressing nerve growth factor in a rat model of diabetic cystopathy. Diabetes 53, 2723\u20132730 (2004).","journal-title":"Diabetes"},{"key":"BFnrurol2012178_CR100","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/j.1464-410X.2008.07757.x","volume":"102","author":"HT Liu","year":"2008","unstructured":"Liu, H. T., Chancellor, M. B. & Kuo, H. C. Urinary nerve growth factor level could be a biomarker in the differential diagnosis of mixed urinary incontinence in women. BJU Int. 102, 1440\u20131444 (2008).","journal-title":"BJU Int."},{"key":"BFnrurol2012178_CR101","first-page":"e69","volume":"12","author":"HC Kuo","year":"2010","unstructured":"Kuo, H. C., Liu, H. T. & Chancellor, M. B. Can urinary nerve growth factor be a biomarker for overactive bladder? Rev. Urol. 12, e69\u2013e77 (2010).","journal-title":"Rev. Urol."},{"key":"BFnrurol2012178_CR102","doi-asserted-by":"crossref","unstructured":"Antunes-Lopes, T., Carvalho-Barros, S., Cruz, C. D., Cruz, F. & Martins-Silva, C. Biomarkers in overactive bladder: a new objective and noninvasive tool? Adv. Urol. 382431 (2011).","DOI":"10.1155\/2011\/382431"},{"key":"BFnrurol2012178_CR103","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S1569-9056(11)60867-1","volume":"10","author":"T Antunes-Lopes","year":"2011","unstructured":"Antunes-Lopes, T. et al. Urinary levels of brain derived neurotrophic factor (BDNF) in women with overactive bladder (OAB) syndrome correlate with the severity of symptoms. Eur. Urol. 10, 277\u2013278 (2011).","journal-title":"Eur. Urol."},{"key":"BFnrurol2012178_CR104","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S0022-5347(01)61915-3","volume":"161","author":"AJ Okragly","year":"1999","unstructured":"Okragly, A. J. et al. Elevated tryptase, nerve growth factor, neurotrophin-3 and glial cell line-derived neurotrophic factor levels in the urine of interstitial cystitis and bladder cancer patients. J. Urol. 161, 438\u2013441 (1999).","journal-title":"J. Urol."},{"key":"BFnrurol2012178_CR105","unstructured":"US National Library of Medicine. ClinicalTrials.gov [online] , (2011)."},{"key":"BFnrurol2012178_CR106","unstructured":"US National Library of Medicine. ClinicalTrials.gov [online] , (2012)."},{"key":"BFnrurol2012178_CR107","unstructured":"US National Library of Medicine. ClinicalTrials.gov [online] , (2011)."},{"key":"BFnrurol2012178_CR108","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1056\/NEJMoa0901510","volume":"363","author":"NE Lane","year":"2010","unstructured":"Lane, N. E. et al. Tanezumab for the treatment of pain from osteoarthritis of the knee. N. Engl. J. Med. 363, 1521\u20131531 (2010).","journal-title":"N. Engl. J. Med."},{"key":"BFnrurol2012178_CR109","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nrd3732","volume":"11","author":"D Holmes","year":"2012","unstructured":"Holmes, D. Anti-NGF painkillers back on track? Nat. Rev. Drug Discov. 11, 337\u2013338 (2012).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnrurol2012178_CR110","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.eururo.2008.09.009","volume":"55","author":"A Apostolidis","year":"2009","unstructured":"Apostolidis, A. et al. Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report. Eur. Urol. 55, 100\u2013119 (2009).","journal-title":"Eur. Urol."},{"key":"BFnrurol2012178_CR111","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.juro.2009.06.024","volume":"182","author":"YC Chuang","year":"2009","unstructured":"Chuang, Y. C., Lee, W. C., Lee, W. C. & Chiang, P. H. Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis\/painful bladder syndrome. J. Urol. 182, 1393\u20131400 (2009).","journal-title":"J. Urol."},{"key":"BFnrurol2012178_CR112","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1124\/jpet.109.159079","volume":"332","author":"JK Eibl","year":"2010","unstructured":"Eibl, J. K., Chapelsky, S. A. & Ross, G. M. Multipotent neurotrophin antagonist targets brain-derived neurotrophic factor and nerve growth factor. J. Pharmacol. Exp. Ther. 332, 446\u2013454 (2010).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnrurol2012178_CR113","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.tips.2005.12.001","volume":"27","author":"FF Hefti","year":"2006","unstructured":"Hefti, F. F. et al. Novel class of pain drugs based on antagonism of, N. G. F. Trends Pharmacol. Sci. 27, 85\u201391 (2006).","journal-title":"Trends Pharmacol. Sci."}],"container-title":["Nature Reviews Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrurol.2012.178.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrurol.2012.178","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrurol.2012.178.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T04:20:53Z","timestamp":1714450853000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrurol.2012.178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,9]]},"references-count":113,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["BFnrurol2012178"],"URL":"https:\/\/doi.org\/10.1038\/nrurol.2012.178","relation":{},"ISSN":["1759-4812","1759-4820"],"issn-type":[{"value":"1759-4812","type":"print"},{"value":"1759-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,9]]}}}